THE anemia of renal insufficiency is associated with both increased red-cell destruction and impaired erythropoietic response to anemia. Variations in the relative importance of these 2 mechanisms and ...
Mouse models have been used extensively for decades and have been instrumental in improving our understanding of mammalian erythropoiesis. Nonetheless, there are several examples of variation between ...
ISTANBUL, Turkey — For hemodialysis-dependent patients with chronic kidney disease, soluble ferric pyrophosphate is as safe as other iron replacements and reduces the need for ...
Two hundred-billion red blood cells are renewed in our body every single day. These erythrocytes (also known as red blood cells) are generated from bi-potent megakaryocyte-erythroid progenitor cells ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 65, No. 4 (Apr. 15, 1970), pp. 919-924 (6 pages) The effects of a number of steroid compounds on erythropoiesis in ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...
Erythropoiesis-stimulating agents (ESAs) are a very effective treatment for reducing the need for transfusions in patients affected by anemia and either chronic kidney disease (CKD) or cancer. However ...
CAMBRIDGE, Mass., Oct. 21 /PRNewswire/ -- Sermo (http://www.sermo.com), the largest online community for physicians, today announced a free Sermo Report titled ...
Most anemic patients with non-deleted 5q lower-risk myelodysplastic syndromes (MDS) are treated with erythropoiesis-stimulating agents (ESAs), with a response rate of approximately 50%. Second-line ...
NOTE. Models also adjusted for Surveillance, Epidemiology, and End Results site. Abbreviations: DO, doctor of osteopathic medicine; ESA, erythropoiesis-stimulating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback